MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 100 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $372,000 | -41.9% | 146,559 | +129.1% | 0.18% | +166.7% |
| Q3 2018 | $640,000 | -17.7% | 63,966 | -41.8% | 0.07% | -90.4% |
| Q2 2018 | $778,000 | +153.4% | 109,991 | +36.8% | 0.69% | +158.6% |
| Q1 2018 | $307,000 | -0.3% | 80,389 | +112.7% | 0.27% | -31.1% |
| Q4 2017 | $308,000 | – | 37,803 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 5,016,164 | $10,835,000 | 2.15% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,836,000 | 1.91% |
| Asymmetry Capital Management, L.P. | 354,853 | $766,000 | 1.37% |
| Lion Point Capital, LP | 6,374,740 | $13,769,000 | 1.28% |
| Granite Point Capital Management, L.P. | 2,700,000 | $5,832,000 | 0.91% |
| VHCP Management II, LLC | 1,486,676 | $3,211,000 | 0.85% |
| Boxer Capital, LLC | 4,800,000 | $10,368,000 | 0.59% |
| Avoro Capital Advisors LLC | 6,200,000 | $13,392,000 | 0.39% |
| 683 Capital Management, LLC | 925,382 | $1,999,000 | 0.23% |
| Islet Management, LP | 875,000 | $1,890,000 | 0.18% |